Mais Jebrail, PhD, is the CTO of Microfluidics at INTEGRA Biosciences and an expert in microfluidics with extensive experience in the biotech industry, ranging from chemistry to clinical applications. He completed his PhD at the University of Toronto and pursued postdoctoral research at Sandia National Labs. At INTEGRA Biosciences, he is driving innovation in microfluidic technologies for life sciences. With a strong background in technology development and commercialization, Dr. Jebrail has contributed to multiple patents and has published many peer-reviewed papers in the areas of microfluidic device design, diagnostic applications, and next-generation sequencing. He continues to push the boundaries of microfluidics in biotechnology.

‍